MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BORSA, J.
Right arrow Articles by WHITMORE, G. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BORSA, J.
Right arrow Articles by WHITMORE, G. F.

Molecular Pharmacology, Vol 5, 303-317, Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics

Studies Relating to the Mode of Action of Methotrexate

II. Studies on Sites of Action in L-Cells in Vitro

J. BORSA 1 and G. F. WHITMORE 1

1 Ontario Cancer Institute and Department of Medical Biophysics, Toronto 5, Ontario, Canada

The methotrexate-induced inhibition of thymidylate and of purine synthesis has been studied in L-cells in tissue culture under conditions which permitted the separation of the two types of inhibition. Data are presented which suggest that under the conditions employed methotrexate may have sites of action in addition to its inhibition of folate and dihydrofolate reductase. These findings are discussed in relation to the strengths and weaknesses of the noe-site-of-action hypothesis.

Note:
ACKNOWLEDGMENTS We thank Drs. W. R. Bruce and J. E. Till for helpful discussions.

Submitted on February 24, 1969







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics